Robert Gallo And The Human Element

There is a nasty little sideshow to the war against AIDS that has wasted precious talent, time, and lives. And it ought to stop. Its target is the National Cancer Institute's Robert Gallo, two-time winner of the Albert Lasker Medical Research Award and America's preeminent retrovirologist. For years, this sideshow has been produced mainly by Chicago Tribune reporter John Crewdson. Recently ABC-TV's Sam Donaldson got into the act on "PrimeTime Live," making his strident contribution to the tast

Written byMarshall Goldberg
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Its target is the National Cancer Institute's Robert Gallo, two-time winner of the Albert Lasker Medical Research Award and America's preeminent retrovirologist. For years, this sideshow has been produced mainly by Chicago Tribune reporter John Crewdson. Recently ABC-TV's Sam Donaldson got into the act on "PrimeTime Live," making his strident contribution to the tasteless assault.

The vilification of Gallo is bitterly ironic, since it is his team--by pushing ahead with the development of a practical HIV blood test--that has saved thousands of people from contracting AIDS through blood transfusions or blood products. While it is true that Pasteur Institute scientists made a key contribution, the HIV blood test--if left to them--would have been delayed by six months or so.

Both Donaldson and Crewdson, hot on the track of scandal involving the HIV test, either overlooked or chose to ignore an obvious fact: Between 3,000 and 5,000 French citizens were infected ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies